Munich, Germany

Abouzar Eslami

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • München, DE (2017 - 2018)
  • Munich, DE (2016 - 2022)
  • Oberkochen, DE (2024)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Abouzar Eslami: Innovator in Surgical Technology

Introduction

Abouzar Eslami is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of surgical technology, holding a total of 9 patents. His work focuses on enhancing surgical procedures through innovative methods and devices.

Latest Patents

Eslami's latest patents include a method for operating a surgical microscope and a treatment apparatus with an optical coherence tomography (OCT) device. The surgical microscope patent describes a system that captures images from both left and right cameras, utilizing machine learning and computer vision to identify target objects and optimize microscope parameters. The treatment apparatus patent involves a modular intraocular lens that improves the accuracy of OCT cross-sectional images, ensuring that the dimensions of markings are correctly represented.

Career Highlights

Abouzar Eslami is currently employed at Carl Zeiss Meditec AG, a leading company in the field of medical technology. His work at the company has allowed him to develop cutting-edge solutions that enhance surgical precision and patient outcomes.

Collaborations

Eslami collaborates with talented coworkers, including Corinna Maier-Matic and Christine Kochwagner. Their combined expertise contributes to the innovative projects at Carl Zeiss Meditec AG.

Conclusion

Abouzar Eslami's contributions to surgical technology through his patents and work at Carl Zeiss Meditec AG highlight his role as a key innovator in the medical field. His inventions continue to advance surgical practices and improve patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…